Fundz

Nano Dimension to merge with Infinite Epigenetics

PUBLIC · NNDMJun 17, 2026

Acquiring Company

Nano Dimension Ltd

Acquired Company

Infinite Epigenetics

BurlingtonManufacturingInformation TechnologySoftwareElectronicsBiotechnologyHealth CareGeneticsHealth Diagnostics

Description

Nano Dimension Ltd. has announced a proposed business combination with Infinite Epigenetics. This merger aims to create significant long-term value for shareholders by combining their respective strengths in advanced diagnostics and biotechnology. The final terms of the merger are still under negotiation, and further details will be shared with shareholders once they are finalized.

Company Information

Company

Nano Dimension Ltd

Location

Burlington, Massachusetts, United States

About

Nano Dimension’s (Nasdaq: NNDM) vision is to transform existing electronics and mechanical manufacturing into Industry 4.0 environmentally friendly & economically efficient precision additive electronics and manufacturing – by delivering solutions that convert digital designs to electronic or mechanical devices - on demand, anytime, anywhere. Nano Dimension’s strategy is driven by the application of deep learning based AI to drive improvements in manufacturing capabilities by using self-learning & self-improving systems, along with the management of a distributed manufacturing network via the cloud. Nano Dimension serves over 2,000 customers across vertical target markets such as aerospace & defense, advanced automotive, high-tech industrial, specialty medical technology, R&D and academia. The company designs and makes Additive Electronics and Additive Manufacturing 3D printing machines and consumable materials. Additive Electronics are manufacturing machines that enable the design and development of High-Performance-Electronic-Devices (Hi-PED®s). Additive Manufacturing includes manufacturing solutions for production of metal, ceramic, and specialty polymers-based applications - from millimeters to several centimeters in size with micron precision. Through the integration of its portfolio of products, Nano Dimension is offering the advantages of rapid prototyping, high-mix-low-volume production, IP security, minimal environmental footprint, and design-for-manufacturing capabilities, which is all unleashed with the limitless possibilities of additive manufacturing. For more information, please visit www.nano-di.com.

Fundz sees it the moment Nano Dimension Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Racheli
Senior decision-maker at this company
••••••••@••••••••

See Racheli's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Nano Dimension Ltd's next move

Learn about Strategic plan

Frequently asked

Who acquired Infinite Epigenetics?

Infinite Epigenetics was acquired by Nano Dimension Ltd, based in Burlington. The deal was reported on June 17, 2026. Nano Dimension Ltd is publicly traded (NNDM) and operates in Manufacturing.

When did Nano Dimension Ltd acquire Infinite Epigenetics?

Nano Dimension Ltd's acquisition of Infinite Epigenetics was reported on June 17, 2026. Nano Dimension Ltd. has announced a proposed business combination with Infinite Epigenetics. This merger aims to create significant long-term value for shareholders by combining their respective strengths in advanced diagnostics and biotechnology. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Infinite Epigenetics do?

Infinite Epigenetics is a biotechnology company focused on advancing diagnostic solutions through epigenetic research. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.